SanofiSNYNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -37.46% | +9.05% | -5.67% | -6.97% | +59.94% |
| Gross Profit Growth | -34.26% | +14.21% | -2.85% | -3.12% | +59.98% |
| EBITDA Growth | +32.47% | +48.37% | -6.76% | -1.15% | +579.04% |
| Operating Income Growth | +67.54% | +84.87% | -7.59% | -0.33% | -281.15% |
| Net Income Growth | +0.00% | +65.23% | +254.00% | -0.46% | -260.52% |
| EPS Growth | +0.00% | +65.22% | +255.56% | +1.77% | -522.86% |
| EPS Diluted Growth | +0.00% | +65.22% | +255.56% | +0.88% | -517.14% |
| Weighted Average Shares Growth | +0.00% | -1.19% | -1.36% | -2.79% | -2.65% |
| Weighted Average Shares Diluted Growth | +0.00% | -1.19% | -1.36% | -1.52% | -2.65% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -100.00% | +0.00% | -100.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -3.72% | +0.00% | -6.79% | +0.00% | -96.27% |
| Inventory Growth | -2.43% | +0.00% | -9.34% | +0.00% | +140.60% |
| Asset Growth | +5.01% | +0.00% | -3.70% | +0.00% | -4.51% |
| Book Value per Share Growth | +4.68% | +0.83% | -2.36% | +0.00% | -5.41% |
| Debt Growth | -4.23% | +0.00% | -7.26% | +0.00% | +13.53% |
| R&D Expense Growth | +13.19% | +8.26% | +12.03% | -0.97% | +8.12% |
| SG&A Expenses Growth | -57.63% | +5.26% | -0.94% | -14.55% | +93.24% |